We are thrilled to be working with AlzeCure Pharmaon their pilot study with Painless ACD440 in peripheral neuropathic pain, where we will implement a new digital element for decentralized activities. This will create a smooth and flexible process for patient recruitment and will help with the pre-screening, eConsent, and remote visits via Viedoc Me while feeding in information to the eCRF.
In this picture, our team collaborates with Viedoc and the participating clinic to create a short information film for the patients. The video will be available through Viedoc during the eConsent process at the beginning of the study.
AlzeCure® is a Swedish pharmaceutical company that develops new innovative small molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer’s disease and pain – indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.
A strategic partnership with LINK Medical offers the expertise and guidance you need to accelerate your time to market.
Contact us to learn how we can help you with your product development using the most efficient tools and the best teams in the industry.
Some cookies are required to give you access to the website, while others are used to upgrade your user experience and are voluntary to accept. Choose below if you agree to us processing cookies to enable and analyze the provision of functionalities by third parties (e.g. social media plugins) and improve your user experience by analyzing your use of the website.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
1 year 1 month 4 days
Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
1 year 1 month 4 days
Google Analytics sets this cookie to store and count page views.
YouTube sets this cookie via embedded YouTube videos and registers anonymous statistical data.